Javascript must be enabled to continue!
OBESITY AND VITAMIN D RECEPTOR (VDR, RS2228570) GENE POLYMORPHISM ASSOCIATION IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION
View through CrossRef
Objective:
The study purpose was to analyze the association of vitamin D receptor (VDR, rs2228570) gene polymorphism with obesity in patients with essential arterial hypertension (EAH).
Design and method:
The study involved 100 patients suffering from EAH with target-organ damaging, moderate, high or very high cardiovascular risk. Among them, 79.0% (79) women and 21.0% (21) men, average age 59,86 ± 6,22 y o. The control group involved 60 practically healthy persons, matched by age and sex distribution. All enrolled/screened patients signed the Informed Consent to participate in the research. To examine polymorphism of VDR (rs2228570) gene a qualitative real-time polymerase chain reaction was made. Obesity was defined as a body mass index (BMI) of > 30 kg/m2.
Results:
The genotypes distribution of the VDR (rs2228570) gene in patients vs control group did not differ reliably and was as follows: AA-, AG-, GG-genotypes – 23.0% vs 30.0%, 50.0% vs 46.67%, 27.0% vs 23.33% (p> 0.05) accordingly. Distribution of the genes polymorphic variants corresponded to the Hardy-Weinberg Equilibrium (p > 0.05).
There were no statistically significant differences in the distribution of BMI between patients with EAH and almost healthy GG-genotype carriers of the VDR gene. AG- and AA-genotype carriers in control group were relatively more likely to register persons with normal BMI (18.5 - 24.9 kg/m2) than among patients - by 14.0 % (x2 = 6.06; p = 0.014) and 15,67 % (p < 0.001). While among A-allele carriers with EAH were more patients with obesity - by 17.67 % (x2 = 9.51; p = 0.002) and 8.67 % (x2 = 3.53, p = 0.05), respectively.
Conclusions:
Regarding polymorphic variants of the VDR gene, in A-allele carriers with EAH (AA-, and especially AG-genotypes) the risk of obesity increases almost 4 and 8 times [OR = 3.95; p = 0.05 and OR = 7.71; p = 0.001] with the lowest probability of having a normal BMI. In this case, the GG-genotype of the VDR gene is not a risk factor for obesity in the population we examined.
Title: OBESITY AND VITAMIN D RECEPTOR (VDR, RS2228570) GENE POLYMORPHISM ASSOCIATION IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION
Description:
Objective:
The study purpose was to analyze the association of vitamin D receptor (VDR, rs2228570) gene polymorphism with obesity in patients with essential arterial hypertension (EAH).
Design and method:
The study involved 100 patients suffering from EAH with target-organ damaging, moderate, high or very high cardiovascular risk.
Among them, 79.
0% (79) women and 21.
0% (21) men, average age 59,86 ± 6,22 y o.
The control group involved 60 practically healthy persons, matched by age and sex distribution.
All enrolled/screened patients signed the Informed Consent to participate in the research.
To examine polymorphism of VDR (rs2228570) gene a qualitative real-time polymerase chain reaction was made.
Obesity was defined as a body mass index (BMI) of > 30 kg/m2.
Results:
The genotypes distribution of the VDR (rs2228570) gene in patients vs control group did not differ reliably and was as follows: AA-, AG-, GG-genotypes – 23.
0% vs 30.
0%, 50.
0% vs 46.
67%, 27.
0% vs 23.
33% (p> 0.
05) accordingly.
Distribution of the genes polymorphic variants corresponded to the Hardy-Weinberg Equilibrium (p > 0.
05).
There were no statistically significant differences in the distribution of BMI between patients with EAH and almost healthy GG-genotype carriers of the VDR gene.
AG- and AA-genotype carriers in control group were relatively more likely to register persons with normal BMI (18.
5 - 24.
9 kg/m2) than among patients - by 14.
0 % (x2 = 6.
06; p = 0.
014) and 15,67 % (p < 0.
001).
While among A-allele carriers with EAH were more patients with obesity - by 17.
67 % (x2 = 9.
51; p = 0.
002) and 8.
67 % (x2 = 3.
53, p = 0.
05), respectively.
Conclusions:
Regarding polymorphic variants of the VDR gene, in A-allele carriers with EAH (AA-, and especially AG-genotypes) the risk of obesity increases almost 4 and 8 times [OR = 3.
95; p = 0.
05 and OR = 7.
71; p = 0.
001] with the lowest probability of having a normal BMI.
In this case, the GG-genotype of the VDR gene is not a risk factor for obesity in the population we examined.
Related Results
Variants of the vitamin D receptor gene and the expression of microRNA‑21, microRNA‑125a, microRNA‑125b and microRNA‑214 in coronary heart disease
Variants of the vitamin D receptor gene and the expression of microRNA‑21, microRNA‑125a, microRNA‑125b and microRNA‑214 in coronary heart disease
Background. The protective effects of vitamin D in relation to atherogenesis are realized by vitamin D receptors (VDR). Variants rs10735810, rs731236, rs1544410 and rs797532 of the...
LIPID DISORDERS AND ESSENTIAL ARTERIAL HYPERTENSION RISK DEPENDING ON AGTR1 (RS5186) AND VDR (RS2228570) GENES POLYMORPHISM
LIPID DISORDERS AND ESSENTIAL ARTERIAL HYPERTENSION RISK DEPENDING ON AGTR1 (RS5186) AND VDR (RS2228570) GENES POLYMORPHISM
Objective:
Hypertension and dyslipidemia represent two of the most relevant modifiable cardiovascular risk factors and they often coexist. The aim of the research was t...
RISK CONFERRED BY POLYMORPHIC VARIANTS OF VITAMIN D RECEPTOR (VDR) AND ANGIOTENSIN II TYPE 1 RECEPTOR (AGTR1) GENES FOR ESSENTIAL HYPERTENSION
RISK CONFERRED BY POLYMORPHIC VARIANTS OF VITAMIN D RECEPTOR (VDR) AND ANGIOTENSIN II TYPE 1 RECEPTOR (AGTR1) GENES FOR ESSENTIAL HYPERTENSION
Objective:
The aim of this study was to establish the role of 1166A>C polymorphism of the AGTR1 gene (rs5186) and A/G polymorphism of the VDR gene (rs2228570) in ris...
Vitamin D plasma concentration and VDR gene polymorphisms in patients with non-dipper hypertension
Vitamin D plasma concentration and VDR gene polymorphisms in patients with non-dipper hypertension
Abstract
The study of the effects of vitamin D today has a high interest in the scientific community.
We det...
Vitamin D and the Immune System. When? Why? How?
Vitamin D and the Immune System. When? Why? How?
Vitamin D, called “the sunshine vitamin” is essential for the good functioning of the human body. Vitamin D generates its principal effects via the vitamin D receptor (VDR), a spec...
P021 Vitamin D receptor-dependent protective effect of moderate hypoxia in a mouse colitis model Running title: Hypoxia prevents mouse colitis through VDR
P021 Vitamin D receptor-dependent protective effect of moderate hypoxia in a mouse colitis model Running title: Hypoxia prevents mouse colitis through VDR
Abstract
Background
Although physiological hypoxia is important for maintaining the intestinal barrier, its effect on the barrie...
Identification of genetic variants affecting vitamin D receptor binding and associations with autoimmune disease
Identification of genetic variants affecting vitamin D receptor binding and associations with autoimmune disease
AbstractLarge numbers of statistically significant associations between sentinel SNPs and case-control status have been replicated by genome-wide association studies. Nevertheless,...
Phenotypic manifestations of arterial hypertension according to polymorphism of vitamin D receptor gene
Phenotypic manifestations of arterial hypertension according to polymorphism of vitamin D receptor gene
Objective. To determine the phenotypic manifestations of essential arterial hypertension (EAH) according to the vitamin D receptor gene polymorphism (VDR rs10735810, rs2228570).Mat...

